Caries Clinical Trial
Official title:
A 24-Month Clinical Evaluation of an Ultra-rapid Polymerizing Resin Composite
Verified date | April 2022 |
Source | Ivoclar Vivadent AG |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The objective of this 2-year split mouth comparative study, a randomized controlled study, is to determine whether the simplified placement procedure of the ultra-rapid polymerizing Tetric PowerFlow/ Tetric PowerFill with a reduced light polymerization time (3 s), yields the same clin-ical results as widely used commercially available dental composites (Tetric EvoCeram Bulk Fill, Tetric EvoFlow Bulk Fill) requiring up to 40 seconds of light polymerization time.
Status | Active, not recruiting |
Enrollment | 51 |
Est. completion date | January 30, 2023 |
Est. primary completion date | January 30, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 80 Years |
Eligibility | Inclusion Criteria: - Each subject must need at least 2 restorations in a vital posterior tooth (in different quadrants) - Restorations may be indicated for caries removal and restoration, replacement of defec-tive restorations (i.e. fractured, stained, unaesthetic), or requested replacement of un-aesthetic restorations. - Must have given written consent to participate in the trial - Must be available for the required follow-up visits over 2 years - Restored teeth must have occlusal contact with opposing teeth or restored teeth - Restoration width should be equal to or greater than 1/3 the distance from buccal to lin-gual cusp tips - 75% of the restorations Class II (minimum) and 25% Class I - One, two or three surfaces per restoration - Each Class II will have at least one proximal contact - 75% in molars (minimum) and 25% in premolars - All restored teeth must have at least one occlusal contact in habitual closure - Must have 20 or more teeth with evidence of bilateral posterior tooth contacts - Teeth that require one or no cuspal build-ups - Vital tooth - Preoperative sensibility on the teeth to be treated at maximum 3 on visual analog scale (10 = maximum) - Patient wishes to be treated in this clinical trial after oral information by the operator and after signing the informed patient form Exclusion Criteria: - Allergies to ingredients of the materials under investigation (monomers) - Do not meet all inclusion criteria above - Have medical complications (organ transplants, long term antibiotic or steroid treatment, cancer or are immunocompromised) or disabilities rendering them unable to tolerate the time required to complete the restorations or to provide adequate oral hygiene - Suffer from xerostomia either by taking medications known to produce xerostomia or those with radiation induced xerostomia or Sjogren's syndrome subjects - Have teeth with advanced or severe periodontitis, rampant caries or poor oral hygiene which may require extraction of the teeth to be restored - Present with any systemic or local disorders that contraindicate the dental procedures included in this study - Patients reporting having severe grinding/bruxing or clenching or in need of TMJ-related therapy - Have tooth with exposed pulp during preparation or caries removal or require indirect pulp capping - Inclusion of teeth that are non-vital or that exhibit signs of pulpal pathology (pulpitis) - If the working field cannot be maintained in a dry state for treatment |
Country | Name | City | State |
---|---|---|---|
United States | University of Illinois College of Dentistry | Chicago | Illinois |
Lead Sponsor | Collaborator |
---|---|
Ivoclar Vivadent AG |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | post-operative tooth sensitivity | assessed by tests with thermal stimuli and occlusal forces (during biting) determined by VAS (Visual Analog Scale, 0 "No pain at all" - 10 "The worst pain imaginable") following the FDI criteria on a scale from 1 "very good" to 5 "unacceptable" | Baseline to 36 months | |
Secondary | restoration quality evaluation | assessed following the FDI criteria on a scale from 1 "very good" to 5 "unacceptable" | Baseline to 36 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05311657 -
Oral Health and Severe COPD
|
||
Not yet recruiting |
NCT06438926 -
Prevalence of Dental Caries in Patients With Dental Crowding
|
||
Completed |
NCT01529606 -
Cold Plasma for Dental Restoration and Caries Prevention
|
N/A | |
Completed |
NCT06072742 -
Effect of Lifestyle on Caries and Apical Periodontitis
|
||
Completed |
NCT04679558 -
Antibacterial Effect of Chlorhexidine Added to the Preventive Protocol in Adolescent Special Needs
|
Early Phase 1 | |
Active, not recruiting |
NCT04933123 -
Clinical Evaluation of a Dental Glass Ceramic in the Indirect Restorative Therapy
|
N/A | |
Withdrawn |
NCT02202304 -
The Effects of Chlorhexidine/Thymol Varnish on Partial Denture Patient
|
Phase 4 | |
Not yet recruiting |
NCT04889196 -
The Efficiency and Gingival Health Status of Hall Versus SDF Techniques in the Management of Carious Primary Molars
|
Phase 3 | |
Completed |
NCT06140745 -
Evaluation of Dentifrice Formulations to Remineralize Enamel and Dentine Subsurface Lesions in a Double-Blind In-Situ Clinical Trial
|
N/A | |
Recruiting |
NCT05144711 -
Management of Deep Carious Lesions in Adults
|
N/A | |
Not yet recruiting |
NCT03656432 -
Effect of CPP-ACP With/Without Fl on White Spot Lesion,Salivary pH and fl Release in High Caries Risk Patients
|
Phase 3 | |
Not yet recruiting |
NCT02933463 -
Clinical Effectiveness of Embrace Wetbond and Clinpro as Pits and Fissure Sealants in Young Permanent Molars
|
N/A | |
Completed |
NCT02998814 -
Clinical Follow Up of a Fissure Sealant Placed With Different Adhesive Protocols: 2-Year Randomized Split Mouth Study
|
N/A | |
Completed |
NCT02027597 -
Improving Oral Health With Serious Games
|
N/A | |
Not yet recruiting |
NCT05064566 -
Evaluation of Caries Detection Methods
|
||
Completed |
NCT06010732 -
In Situ Comparison of the Remineralization Potential of Optimized Fluoride Dentifrice With Control Fluoride Dentifrice
|
Phase 3 | |
Recruiting |
NCT05211843 -
Saliva Insulin as Biomarker of Risk Factors for Metabolic Dysregulation and Caries
|
N/A | |
Not yet recruiting |
NCT05070416 -
Lithium Disilicate Crowns Study
|
N/A | |
Completed |
NCT02418520 -
The Effect of Miswak Chewing Sticks on the Oral Helicobacter Pylori Infection
|
N/A | |
Completed |
NCT04286256 -
Using Motivational Interviewing To Reduce Parental Risk-Related Behaviors For Early Childhood Caries
|
N/A |